ANAEROBE TARGETED ENZYMEMEDIATED PRODRUG THERAPY

Details for Australian Patent Application No. 2003249679 (hide)

Owner THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY

Inventors GIACCIA, Amato, J.; MINTON, Nigel, P.; BROWN, John, M.; LIU, Shie-Chau

Pub. Number AU-A-2003249679

PCT Number PCT/US03/17291

PCT Pub. Number WO2003/102169

Priority 10/158,976 31.05.02 US

Filing date 30 May 2003

Wipo publication date 19 December 2003

International Classifications

C12N 001/20 Micro-organisms, e.g. protozoa - Bacteria

C12N 015/74 Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 10/158,976 31.05.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-A-2003249679

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

18 August 2005 Corrigenda

  Applications OPI - Name Index Under the name THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, Application No. 2003249679, under INID (71) correct the name to read CENTRE FOR APPLIED MICROBIOLOGY & RESEARCH; THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003249680-Liquid formulation of decitabine and use of the same

2003249678-Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease